The Erling-Persson Family Foundation
The Erling-Persson Family Foundation supports projects in science, education, and development of children and young people. In its support of scientific research the foundation prioritizes projects with a focus on medicine and healthcare. In 2018, the Foundation awarded close to SEK 66 million to researchers at KI. Previously, the university has also received a large donation for building the new Aula Medica.
Project: Developing membrane particles for a vaccination strategy with broader effect than present ones against pneumococcal infections
Birgitta Henriques Normark, Department of Microbiology, Tumor and Cell Biology, is awarded SEK 9 million over 3 years.
Project: Treatment against prostate cancer – PSMA/PET controlled treatment compared to conventional radiation therapy, a randomized study.
Stefan Carlsson, Department of Molecular Medicine and Surgery, is awarded SEK 7.5 million over 3 years.
Project Cardiovascular research with magnetic camera, MR Thorax
Lars Rydén, Department of Medicine, Solna, is awarded SEK 12.7 million over 3 years.
Project: The Human Developmental Cell Atlas
Sten Linnarsson, Department of Medical Biochemistry and Biophysics, is co-applicant in a project led from KTH that has been awarded SEK 60 million over 4 years.
Project: Acquired muscle paralysis in intensive care unit patients: Mechanisms, diagnosis/monitoring and treatment
Lars Larsson, Department of Physiology and Pharmacology, receives SEK 6 million over a period of three years for his research on a type of muscle paralysis that affects some patients in intensive care.
Read more on KI News
Project: Patient-related diagnosis of cancer and infectious diseases with mobile digital microscope and artificial intelligence
Johan Lundin, Department of Global Public Health, receives SEK 6 million over a period of three years for his research on better tools for diagnosing severe diseases.
Project: Developing a vaccine against rheumatoid arthiritis
Rikard Holmdahl, Department of Medical Biochemistry and Biophysics, receives SEK 9 million over a period of tree years for research about vaccines against rheumatism
Project: A platform for and conduct of the first Registry-Randomized Clinical Trial in heart failure: The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFPEF)
Dr Lars H. Lund, Department of Medicine, Solna, received SEK 10 million over a period of three years for developing a platform for registry-based randomized clinical trials in heart failure. This project is conducted in collaboration with the Swedish national heart failure registry, RiksSvik, and Uppsala Clinical Research Center.
Project: The Individualized Prostate Cancer Diagnosis Pipeline
Professor Henrik Grönberg, Department of Medical Epidemiology and Biostatistics, received SEK 28 million over a period of three years for the further development of the Stockholm3 test, aiming towards improved prostate cancer diagnosis. Partners in this project are the Karolinska University Hospital, Stockholm County Council and Prostate Cancer UK.
Project: Is Malaria elimination possible in Zanzibar? A case study for Africa.
Professor Anders Björkman, Department of Microbiology, Tumor and Cell Biology, received SEK 3 million over a three year period for his research into the possible elimination of Malaria in Zanzibar. Partner in this project is the Zanzibar Malaria Control Program. Additional grant in 2018: SEK 2 million.
Professors Kerstin Brismar and Per-Olof Berggren, Department of Molecular Medicine and Surgery, have received funding of SEK 25 million per year in five years.
Read more at the Foundation’s web site “We are working to cure diabetes”